Investigational Site Number :3800007

Meldola, Forlì-Cesena 47014

0 studies enrolling now · 1 studies all time

What they study most

Neoplasm

Studies at this site

• Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignancies — Stopped early